The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan

Christopher Horan, Chief Technical Operations Officer, Artiva Biotherapeutics joins Cell & Gene: The Podcast Host, Erin Harris, to discuss the advantages natural killer (NK) cells have offer over T cells in terms of safety and efficacy for autoimmune disease. They take a deep dive into the key factors that make NK cells promising for ‘off-the-shelf’ cell therapy products. They cover Artiva's "manufacturing first" approach to enabling scalable NK cell production, and much more.
Email Erin at [e-mail] with topics you'd like us to cover in future episodes.
--
#celltherapy #genetherapy
Subscribe to the podcast!
Apple - podcasts.apple...
Spotify - open.spotify.c...
KZbin - • Cell & Gene The Podcast